Can a Weight-Loss drug protect muscle and bone in seniors? new study aims to find out
NCT ID NCT06861439
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study is testing the drug tirzepatide (Zepbound) in 40 older adults with obesity to see how it affects body composition, bone density, and physical function over nine months. Participants take weekly injections, track their diet and activity, and attend regular check-ins. The goal is to understand if tirzepatide can help older adults lose fat without losing muscle or bone strength.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tirzepatide (Zepbound)
What this could lead to
If successful, this could show that tirzepatide helps older adults lose fat while preserving muscle and bone, pointing toward safer weight management in this age group.
What could go wrong
This is a small pilot study with only 40 participants and no comparison group, so results may not apply broadly. Tirzepatide can cause side effects like nausea or digestive issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States